Eligible patients include those with a body mass index, or BMI, of 35 or higher as well as some people with lower BMIs who have at least one related condition, such as prediabetes, a previous heart attack or stroke, or blocked arteries in their arms or legs
Ozempic and Zepbound branded options are listed at $1,299/month and $1,399/month respectively - substantially higher, which reflects the cost of FDA-approved branded medications versus compounded alternatives
Includes structured care with labs, testing, and monitoring based on insurance coverage
First Mover States in GLP-1 Coverage Colorado No state garnered more attention than Colorado
PMID 8112494
However, real-world experience and the pharmacokinetic principles of volume of distribution suggest that lighter individuals benefit from a more conservative start, while heavier individuals may tolerate a slightly more aggressive approach